Clever Culture Systems LimitedASX: CC5

Instrument Sale to Novo Nordisk for Group Evaluation

· Issued by Clever Culture Systems Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The evaluation will assess the performance of the APAS® technology in reading microbiology culture plates used in environmental monitoring. This sale aligns with the company's strategy to partner with major pharmaceutical manufacturers to improve their practices globally. The company expects to announce further evaluations and sales to additional large multinational pharmaceutical customers in the upcoming fiscal year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Clever Culture Systems Limited on 6ix

Earlier from Clever Culture Systems

Later from Clever Culture Systems

All Clever Culture Systems news releases